Immunogen | 보통주 자본



보통주 자본 변화 날짜
AbbVie USD 1.77B 1.75B 2025-06
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Amgen USD 539M 1000K 2025-12
Astellas Pharma JPY 1.79B 195K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Emergent BioSolutions USD 100K 0 2023-06
Exelixis USD 268.1M 2.03M 2025-09
Halozyme Therapeutics USD 117.78M 259K 2025-12
Heron Therapeutics USD 1.52M 14K 2024-09
Intrexon USD 0 0 2024-06
Karyopharm Therapeutics USD 13K 0 2024-09
MacroGenics USD 63.26M 62.63M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Novartis USD 1.92B 17.06M 2025-09
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12


Immunogen 보통주 자본 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.